European Union fines biotech giant Illumina $475 million for taking over cancer-screening company Grail without approval

· Breaking News · By ReportWire
European Union fines biotech giant Illumina 5 million for taking over cancer-screening company Grail without approval

European Union fines biotech giant Illumina $475 million for taking over cancer-screening company Grail without approval

BRUSSELS — European Union fines biotech giant Illumina $475 million for taking over cancer-screening company Grail without approval.

Source link